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Introduction: Few data are available concerning structural changes at the hip observed by magnetic resonance
imaging (MRI) in people with or without hip osteoarthritis (OA). The aim of this study was to compare cartilage
volume and the presence of cartilage defects and bone marrow lesions (BMLs) in participants with and without
diagnosed hip OA.
Methods: Femoral head cartilage volume was measured by MRI for 141 community-based persons with no diagnosed
hip OA, and 19 with diagnosed hip OA. Cartilage defects and BMLs were regionally scored at the femoral head and
acetabulum.
Results: Compared with those without diagnosed hip OA, people with diagnosed hip OA had less femoral head
cartilage volume (1763 mm3 versus 3343 mm3; p <0.001) and more prevalent cartilage defects and BMLs (all p ≤0.05)
at all sites other than the central inferomedial region of the femoral head. In those with no diagnosed hip OA, cartilage
defects in the anterior and central superolateral region of the femoral head were associated with reduced femoral
head cartilage volume (all p ≤0.02). Central superolateral BMLs at all sites were associated with reduced femoral head
cartilage volume (all p ≤0.003), with a similar trend occurring when BMLs were located in the anterior region of the hip
(all p ≤0.08).
Conclusions: Compared with community-based adults with no diagnosed hip OA, people with diagnosed hip OA
have less femoral head cartilage volume and a higher prevalence of cartilage defects and BMLs. For people with no
diagnosed hip OA, femoral head cartilage volume was reduced where cartilage defects and/or BMLs were present in
the anterior and central superolateral regions of the hip joint. Cartilage defects and BMLs present in the anterior and
central superolateral regions may represent early structural damage in the pathogenesis of hip OA.Introduction
Osteoarthritis (OA) of the knee and hip are common
clinical problems and major causes of pain, disability
and cost to the community through joint replacement
surgery. Through non-invasive assessment of the knee
using magnetic resonance imaging (MRI), a large body
of research has examined knee structures from health
through to disease [1]. Such data have contributed to
better understanding early pathological changes in the
knee joint, and how these relate to symptoms and pro-
gression of knee OA. Structural abnormalities such as* Correspondence: flavia.cicuttini@monash.edu
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stated.bone marrow lesions (BMLs) and focal cartilage defects
have been shown to predate cartilage volume loss and
subsequent radiographic joint disease, as well as joint
replacement in knee OA [2-6]. Such advances have
resulted in novel, albeit experimental, preventive and
therapeutic approaches to knee OA, whereby modifica-
tion of these lesions can be assessed as an outcome for
early disease progression [7-9]. Despite the significant
burden of hip OA, few studies have examined the struc-
tural changes at the hip in OA, and how these differ
from those without diagnosed disease. This is primarily
because it has been challenging to develop MRI proto-
cols that adequately visualise the deeply located and
complex structure of the hip joint in three-dimensional
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hip OA result from different pathogenic processes. For
example, whereas obesity and the metabolic syndrome
are major risk factors for the structural changes in knee
OA, neither obesity nor the metabolic syndrome has
been shown to be a consistent or strong risk factor for
hip OA [10,11]. Therefore, the causes and correlates of
structural changes in knee OA cannot simply be extrap-
olated to the structural changes in hip OA. Most studies
examining structural changes in hip OA have focussed
on radiographic assessment but, as at the knee, a major
limitation is that radiographs do not capture the early
structural changes that may occur before joint symp-
toms are recognised. By the time early radiographic joint
space narrowing of the hip is detected, 13% of femoral
head cartilage volume has already been lost [12]. Sparse
data are available examining structural changes in the
hip joint in individuals without diagnosed hip OA, and
whether these changes may be associated with hip OA.
Moreover, no data are available on the location specific
significance of structural abnormalities at the hip. At the
knee, a disproportionate amount of damage is located in
the medial, rather than the lateral compartment. At-
tempts have been made to characterise regional struc-
tural damage at the hip, but these have been limited by
small sample sizes and have not provided any regional
prevalence data [13,14].
As MRI has enabled a better understanding of the im-
pact of knee OA from early through to established joint
disease, we performed a cross-sectional MRI study to
examine the prevalence and interrelationships of MRI-
determined structural abnormalities in people with and
with no diagnosed hip OA in a region-specific manner.
Methods
Participants
Participants with no diagnosed hip OA
A total of 141 community-based adults with no diagnosed
hip OA were recruited between 2009 and 2010 from the
Melbourne Collaborative Cohort Study (MCCS), a pro-
spective cohort study of 41,514 residents of Melbourne,
Australia, aged 40 to 69 years at MCCS inception (1990 to
1994), examining healthy ageing [15]. Participants were
eligible for the current study if they were aged 50 to
85 years without any of the following exclusion criteria:
diagnosis of hip OA made by a medical or allied health
professional; significant hip pain lasting for >24 hours in
the last 5 years; a previous hip injury requiring non-
weight bearing treatment for >24 hours or surgery
(including arthroscopy); a malignancy; a history of any
form of arthritis diagnosed by a medical practitioner; or
a contraindication to MRI including pacemaker, metal
sutures, presence of shrapnel or iron filings in the eye, or
claustrophobia.Participants with diagnosed hip OA
For comparative purposes, 19 people aged 50 to 79 years
who fulfilled the American College of Rheumatology
(ACR) classification for a diagnosis of clinical hip OA [16]
were recruited between 2009 and 2010 using a conve-
nience sample by advertising in the local community. Par-
ticipants with a diagnosis of hip OA had a hip radiograph
performed on their symptomatic joint to confirm the
presence of radiographic hip OA (Kellgren-Lawrence
grade ≥2) prior to MRI. Any person was excluded if they
had any malignancy or contraindication to MRI. The study
was approved by Human Research Ethics Committees of
The Cancer Council Victoria, Monash University, and
University of Melbourne. All participants gave written in-
formed consent.Anthropometric data
Anthropometric data were collected at the time of MRI
(2009 to 2010). Height was measured using a stadiometer
and weight using electronic scales. Body mass index
(BMI) (weight/height2, kg/m2) was calculated.MRI measurements
Between 2009 and 2010, participants with no diagnosis of
hip OA had an MRI performed on their dominant hip,
defined by the leg used to kick a ball (89% right-sided),
and those with a diagnosis of hip OA had an MRI of
their affected hip. Hips were imaged on a 3.0-T whole
body magnetic resonance unit (Siemens, Verio, Siemens
Medical, Germany) using a phased array flex coil. Sagittal
images were obtained using a T2-weighted fat-suppressed
3-dimensional gradient-recalled acquisition sequence in
the steady state (repetition time 14.45 msec, echo time
5.17 msec; flip angle 25°, slice thickness 1.5 mm, field of
view 16 cm, pixel matrix 320 × 320, acquisition time 7 mi-
nutes 47 sec, and 1 acquisition). Coronal images were ob-
tained using a fat saturation, proton density, spin echo
acquisition sequence (repetition time 3,400 msec, echo
time 64 msec, flip angle 90°, slice thickness 3 mm, field of
view 16 cm, pixel matrix 256 × 256, acquisition time 5 mi-
nutes 26 sec, and 1 acquisition). The same protocol at the
same location, using the same MRI scanner occurred re-
gardless of whether a participant had diagnosed hip OA
or not. A musculoskeletal radiologist with over 15 years
experience using structural outcomes determined by MRI
in epidemiological studies supervised and independently
monitored measurements. One observer, trained by the
radiologist was responsible for measuring one structural
outcome (for example, cartilage volume, cartilage defects
or BMLs). Each observer was also required to assess their
designated structural measure in duplicate, at least one
week apart and blinded to their previous assessment and
characteristics of the participants.
Figure 1 Regional zones of the hip joint. (a) Sagittal image
depicting the anterior, central and posterior regions; (b) coronal
image depicting the central superolateral and inferomedial regions.
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T2-weighted sagittal images using the software Osiris
(version 4.19; Geneva University Hospital, Geneva,
Switzerland) as previously described [12]. The volume
of the femoral head cartilage was isolated from the total
volume by manually drawing disarticulation contours
around the cartilage boundaries on each image section.
These data were then resampled by bilinear and cubic
interpolation for the final 3-dimensional rendering. The
volume of the femoral head cartilage was determined by
summing all the pertinent voxels within the resultant
binary volume. Femoral head cartilage volume was mea-
sured in duplicate with at least a 1-week interval by one
trained observer. The coefficient of variation (CV) was
2.5% [12]. The intra-observer reproducibility assessed
by intra-class correlation coefficient (ICC) was 0.99.
The hip joint was divided into three regions: central, an-
terior and femoral. The anterior and posterior regions
were assessed in the sagittal plane and corresponded to
the first and last three coronal slices (9 mm) (Figure 1a).
The area in between the anterior and posterior region was
termed the central region. The central region was further
subdivided in the coronal plane (Figure 1b). The intersec-
tion of the axis of the femoral head and neck was consid-
ered to be the midpoint of the region, with the axis of the
femoral neck used to demarcate the central superolateral
from the central inferomedial region. The central supero-
lateral and inferomedial regions were then further sub-
divided for exploratory analyses. The division of anterior,
central and posterior regions was adapted from methods
used in previously published works [13,14].
Femoral head and acetabular cartilage defects were
assessed from proton density coronal images and con-
firmed on sagittal imaging for the central region, and
from the sagittal imaging only for the anterior and pos-
terior regions. The presence of cartilage defects was
defined as loss of cartilage thickness of more than 50%
which was shown on at least two consecutive slices. One
trained observer, who was blinded to participant’s cha-
racteristics, assessed the presence of cartilage defects for
each participant in duplicate, at least one week apart.
The ICC for intra-observer reproducibility was 0.72.
Cartilage defects were only assessed at the central super-
olateral region of the acetabulum because there was no
cartilage at the inferomedial region of the acetabulum,
an observation corroborated both by a previous MRI
study [13] and at arthroscopy [17].
Femoral head and acetabular BMLs were assessed on
fat-suppressed proton density coronal images in the
regions as described for cartilage defects. BMLs were de-
fined as areas of increased signal intensity in subchon-
dral regions in the femoral head and acetabulum. The
presence of a BML was defined if it appeared on two or
more adjacent slices and was visible both in the sagittaland coronal planes. One trained observer, who was
blinded to participants' characteristics, assessed the pre-
sence of BMLs for each participant in duplicate, at least
one week apart. The ICC for intra-observer reproduci-
bility was 0.94.
The sagittal image closest to the centre of the femoral
head was used to measure the femoral head bone area.
It was measured by drawing contours around the femo-
ral head bone, and area calculated automatically by the
Osiris program as an indicator of bone size. Femoral
head bone area was measured by one trained observer
with random crosschecks performed by a second obser-
ver. The CV was 1.1% [12]. The ICC for inter-observer
reproducibility was 0.99.
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Between-group differences for people with and without
diagnosed hip OA were assessed using either chi-square
analysis for dichotomous variables or the independent
samples t-test when the variable was continuous. Mul-
tiple linear regression analysis was used to determine the
relationship between femoral head cartilage volume and
other hip structural abnormalities in participants with-
out clinical hip OA. A P-value <0.05 (two-tailed) was
regarded as statistically significant. All analyses were
performed using the SPSS statistical package (standard
version 20.0 SPSS, Chicago, IL, USA).
Results
Participant characteristics are shown in Table 1.
People with hip OA were younger than the non-OA
cohort (59.2 years versus 66.8 years; P <0.001) and
had smaller femoral head cartilage volume (1,763 mm3
versus 3,343 mm3; P <0.001) (Table 1).
Figure 2 depicts the prevalence of central cartilage de-
fects and BMLs for people both with and without diag-
nosed hip OA. Cartilage defects and BMLs were more
prevalent in people with, compared to those without di-
agnosed hip OA in all regions (all P ≤0.05), excluding
cartilage defects in central inferomedial regions 1 and 2
of the femoral head. When these results were adjusted
for age, gender and BMI, results were unchanged (data
not shown).
As shown in Table 1, the prevalence of combined cen-
tral superolateral and inferomedial cartilage defects and
BMLs was significantly greater in people with hip OA
(all P <0.001), excluding the combined central inferome-
dial region of the femoral head (P = 0.68). The prevalence
of anterior and posterior cartilage defects and BMLs were
significantly greater in people with, than those without
diagnosed hip OA (all P <0.001) (Table 1). When these re-
sults were adjusted for age, gender and BMI, results were
unchanged (data not shown). Moreover, we also examined
whether the difference in femoral head cartilage volume
between groups was attributable to variation in the base-
line variables for age, gender, BMI and femoral head bone
area. After adjusting for these factors, femoral head car-
tilage volume remained significantly lower in people with
diagnosed hip OA (estimated marginal means: 1656 mm3
versus 3357 mm3, P <0.001).
As cartilage volume was significantly reduced in par-
ticipants with diagnosed hip OA, the associations bet-
ween femoral head cartilage volume and the presence of
cartilage defects and BMLs were examined in people
without diagnosed hip OA (Tables 2 and 3). The small
sample size precluded such analyses in that subgroup of
people with diagnosed hip OA (n = 19).
The associations between hip cartilage defects and fe-
moral head cartilage volume in people with no diagnosedhip OA are shown in Table 2. After adjusting for age, gen-
der, BMI and femoral head bone area, reduced femoral
head cartilage volume was associated with the presence of
cartilage defects at the anterior femoral head (β −800 mm3,
95% CI −1246 to −354 mm3, P = 0.001), anterior acetabu-
lum (β −259 mm3, 95% CI −478 to −41 mm3, P = 0.02)
and anterior femoroacetabular (β −277 mm3, 95% CI −491
to −63 mm3, P = 0.01) sites. The presence of cartilage de-
fects at any posterior site tended towards being associated
with reduced femoral head cartilage volume, but these
relationships did not reach statistical significance (P = 0.08
to 0.11). In the central region, defects in the central
superolateral, but not central inferomedial regions of the
femoral head were associated with reduced femoral head
cartilage volume (β −283 mm3, 95% CI −460 to −106 mm3,
P = 0.002).
The associations between hip BMLs and femoral head
cartilage volume in people with no diagnosed hip OA are
shown in Table 3. After adjusting for age, gender, BMI and
femoral head bone area, reduced femoral head cartilage
volume was associated with the presence of BMLs at the
anterior femoral head (β −684 mm3, 95% CI −1260
to −108 mm3, P = 0.02), and tended toward significance at
the anterior acetabulum (P = 0.08) and femoroacetabulum
(P = 0.05). The presence of BMLs in the posterior regions
was not significantly associated with a reduction in fem-
oral head cartilage volume. Central superolateral BMLs at
any of the femoral head (β −610 mm3, 95% CI −990
to −229 mm3, P = 0.002), acetabulum (β −250 mm3, 95%
CI −557 to −123 mm3, P = 0.003) or femoroacetabular
sites (β −373 mm3, 95% CI −583 to −164 mm3, P = 0.001)
were associated with reduced femoral head cartilage vo-
lume. No significant association was observed for central
inferomedial BMLs.
Discussion
Compared with community-based adults with no diag-
nosed hip OA, people with diagnosed hip OA have
lower femoral head cartilage volume and a higher pre-
valence of cartilage defects and BMLs. For people with
no diagnosed hip OA, both BMLs and cartilage defects
in the anterior femoral head and central superolateral
hip are associated with decrease hip joint cartilage vo-
lume, while BMLs and cartilage defects of the infero-
medial femur are not. Cartilage lesions of the anterior
acetabulum and anterior femoroacetabular region are
also associated with decreased cartilage volume. These
data demonstrate that cartilage defects and BMLs pre-
sent in the anterior and central superolateral hip are as-
sociated with decreased cartilage volume, which is seen
in hip OA, and may represent early structural changes
of OA.
In this study we found that those with diagnosed hip
OA had significantly less femoral head cartilage than






(n = 19) (n = 141)
Age, years 59.2 (7.6) 66.8 (7.3) <0.0012
Gender, % female 57.9 55.6 0.85









1763 (321) 3343 (808) <0.0012
Femoral head bone
area, mm2




Central superolateral 17 (89.5) 45 (31.9) <0.001
Central inferomedial 10 (52.6) 67 (47.5) 0.68
Anterior 12 (63.2) 5 (3.5) <0.001
Posterior 14 (73.7) 25 (17.6) <0.001
Acetabular
Central superolateral 17 (89.5) 37 (26.2) <0.001
Anterior 18 (94.7) 26 (18.3) <0.001
Posterior 15 (78.9) 50 (35.2) <0.001
Femoroacetabular
Central superolateral 18 (94.7) 64 (45.1) <0.001
Anterior 18 (94.7) 27 (19) <0.001




Central superolateral 10 (52.6) 7 (5.0) <0.001
Central inferomedial 6 (31.6) 6 (4.3) <0.01
Anterior 7 (36.8) 2 (2.1) <0.001
Posterior 5 (26.3) 4 (2.8) <0.001
Acetabular
Central superolateral 13 (68.4) 22 (15.6) <0.001
Central inferomedial 2 (10.5) 3 (2.1) 0.05
Anterior 13 (68.4) 28 (19.7) <0.001
Posterior 11 (57.9) 18 (12.7) <0.001
Table 1 Participant characteristics (Continued)
Femoroacetabular
Central superolateral 14 (73.7) 27 (19.0) <0.001
Central inferomedial 6 (31.6) 8 (5.6) <0.001
Anterior 14 (73.7) 29 (20.4) <0.001
Posterior 13 (68.4) 20 (14.1) <0.001
Results displayed as mean (±SD) unless otherwise stated. All central regions
results are the combined prevalence of regions 1 and 2. 1P-value for
differences between groups (chi-square test unless otherwise stated).
2Independent samples t-test.
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vious study that showed that reduced femoral head cartil-
age volume was associated with more severe radiographic
joint space narrowing [12]. It has been shown that there is
a 13% mean reduction in femoral head cartilage volume,
or a 9% mean reduction in cartilage thickness, with each
increase in grade of radiographic joint space narrowing
[12]. In our study, people with diagnosed hip OA had ap-
proximately half the volume of femoral head cartilage as
people without, after adjusting for age, gender, BMI and
femoral head bone area.
There are limited data on the prevalence of cartilage
defects and BMLs in people with or without hip OA. Al-
though previous MRI studies have attempted to charac-
terise the prevalence of regional structural abnormalities
[13,14], these have been limited by a small sample size
and to our knowledge, have not provided regional pre-
valence data. The current study is the first to have
documented prevalence data for regional structural abnor-
malities. Kumar et al. demonstrated that cartilage defects
and BMLs were associated with greater self-reported pain
and disability, and that acetabular cartilage defects were
more common in people with radiographic hip OA than
those without [13]. We have extended this work and de-
monstrated that compared with people with no diagnosed
hip OA, cartilage defects and BMLs are generally more
common in all regions of the OA hip joint, excluding the
central inferomedial region.
We aimed to determine the relationships between hip
structures in those without diagnosed hip OA to help bet-
ter understand the pathogenesis of early hip OA. Thus,
we excluded participants with diagnosed hip OA. Such
analyses have not previously been performed. Using the
analogy of the knee where it has been shown that the
presence of cartilage defects predict cartilage volume loss
and joint replacement surgery [18,19], we examined the
association between regional cartilage defects and femoral
head cartilage volume. Our data show that in people
without diagnosed hip OA, cartilage defects in the an-
terior region of any one of the femoral head, acetabulum
or combined femoroacetabular regions are associated with
reduced femoral head cartilage volume. Similarly, cartilage
defects in the central superolateral region of the femoral
Figure 2 Prevalence of cartilage defects (a and b) and bone marrow lesions (c and d) in people with and without diagnosed hip
osteoarthritis (OA). *P <0.05. Note: without OA should line up with columns a and c, while with OA lines up with b and d in a 2 × 2 set-up.
Table 2 The associations between hip cartilage defects and femoral head cartilage volume in people with no
diagnosed hip osteoarthritis (n = 141)
Univariate P-value Multivariate* P-value
β (95% CI) β (95% CI)
Femoral head
Central superolateral −184 (−471, 104) 0.21 −283 (−460, −106) 0.002
Central inferomedial −35 (−305, 234) 0.80 −11 (−180, 158) 0.90
Anterior −357 (−1083, 371) 0.33 −800 (−1246, −354) 0.001
Posterior −80 (−432, 273) 0.66 −198 (−421, 25) 0.08
Acetabular
Central superolateral −117 (−423, 188) 0.45 −35 (−228, 158) 0.72
Anterior −320 (−664, 23) 0.08 −259 (−478, −41) 0.02
Posterior 251 (−27, 530) 0.08 −151 (−336, 33) 0.11
Femoroacetabular
Central superolateral −201 (−469, 67) 0.14 −153 (−324, 17) 0.08
Anterior −332 (−671, 6) 0.05 −277 (−491, −63) 0.01
Posterior 138 (−135, 411) 0.32 −144 (−321, 32) 0.11
*Adjusted for age, gender, body mass index and femoral head bone area. All central results are combined prevalence of regions 1 and 2.
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Table 3 The associations between hip bone marrow lesions and femoral head cartilage volume in people with no
diagnosed hip osteoarthritis (n = 141)
Univariate P-value Multivariate* P-value
β (95% CI) β (95% CI)
Femoral head
Central superolateral −106 (−727, 515) 0.74 −610 (−990, −229) 0.002
Central inferomedial −406 (−1071, 259) 0.23 32 (−405, 469) 0.89
Anterior −247 (−1182, 687) 0.60 −684 (−1260, −108) 0.02
Posterior −553 (−1360, 255) 0.18 −380 (−891, 131) 0.14
Acetabular
Central superolateral −125 (−496, 246) 0.51 −250 (−577. -123) 0.003
Central inferomedial −646 (−1575, 283) 0.65 −230 (−821, 360) 0.44
Anterior −241 (−578, 95) 0.16 −189 (−400, 21) 0.08
Posterior 110 (−294, 514) 0.59 −16 (−274, 242) 0.90
Femoroacetabular
Central superolateral −59 (−401, 284) 0.74 −373 (−583, −164) 0.001
Central inferomedial −468 (−1046, 110) 0.11 −80 (−452, 292) 0.67
Anterior −266 (−597, 64) 0.11 −207 (−415, 1) 0.05
Posterior 77 (−310, 463) 0.70 −50 (−296, 196) 0.69
*Adjusted for age, gender, body mass index and femoral head bone area. All central results are combined prevalence of regions 1 and 2.
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volume. Although cartilage defects were more prevalent
in the posterior and central inferomedial regions than the
anterior and central superolateral regions, it was only
cartilage defects located in the anterior and central super-
olateral regions that were significantly associated with
reduced femoral head cartilage volume. This provides the
first evidence that cartilage defects in the anterior and
central superolateral femoral head regions may be asso-
ciated with early structural changes of hip OA.
At the knee, BMLs have been associated with pain,
cartilage loss and joint replacement [2,6]. Little is known
about BMLs at the hip. In people with no diagnosed hip
OA, we have demonstrated that BMLs in the central
superolateral region of the femoral head, acetabulum
and femoroacetabular regions were all significantly asso-
ciated with reduced femoral head cartilage volume. Like-
wise, a BML in the anterior region of the femoral head
was associated with reduced femoral head cartilage vol-
ume. Nevertheless, it is important to acknowledge that
there was a low prevalence of BMLs in the anterior fe-
moral head in people without diagnosed hip OA (2.4%).
However, the number of people with BMLs in the anter-
ior femoroacetabular region was considerably higher
(20.4%), and the association between anterior femoroa-
cetabular BMLs and reduced femoral head cartilage
volume still tended toward significance (P = 0.05).
This is the first study to examine the associations bet-
ween the presence of cartilage defects and BMLs seenon MRI and femoral head cartilage volume in people
with no diagnosed hip OA. A unifying theme to emerge
from these data is the location-specific importance of
BMLs and cartilage defects. Although a previous study
attempted to distinguish differences in the locations of
MRI lesions, a small sample size (n = 90) precluded ana-
lyses [13] and the authors noted that future studies are
needed to evaluate the effect of the location of structural
lesions. Another study of an even smaller sample (n = 50)
examined a host of MRI determined structural abnor-
malities in a region-specific manner, but did not provide
any regional prevalence data [14]. We have addressed this
issue by providing prevalence data and in addition, de-
monstrated that for people without hip OA, cartilage
defects and BMLs in the anterior and central superolateral
regions were associated with reduced femoral head car-
tilage volume. In a previous study, cartilage defects in the
anterior and superior regions of both femur and acetabu-
lum were associated with worse self-reported disability
[13]. Such lesions may therefore have the propensity to
modify femoral head cartilage volume and symptoms, and
determining risk factors for such lesions could provide an
important therapeutic target to help reduce the onset or
slow the progression of hip OA. Such claims will however
need investigation in future studies. Nevertheless, the lo-
cation specific importance of structural abnormalities at
the hip joint may suggest that local biomechanical risk
factors are important in their pathogenesis. Femoro-
acetabular impingement (FAI), a major cause of early hip
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tributed to by either or both an aspherical femoral head
(cam deformity) or focal or generalised acetabular over-
coverage (pincer deformity), acting as a physical impedi-
ment to joint range of movement. Several smaller studies
demonstrated that the cartilage damage observed among
people with cam deformity was in a similar location to the
damage we observed in the anterior and central supero-
lateral regions of the hip [20-22].
This study had several limitations. The cross-sectional
nature of this study precludes any causal effect between the
role of variables such as cartilage defects and BMLs in the
development of hip OA to be identified. Longitudinal stud-
ies will be required to determine these relationships. Al-
though only a modest number of people with diagnosed
hip OA were examined in this study, we noted a number of
significant differences between people with and without
diagnosed hip OA, suggesting that this study was not
underpowered to detect these differences. Participants with
diagnosed hip OA were not matched with participants
without diagnosed hip OA. Thus participants with diag-
nosed hip OA were significantly younger than those with-
out a diagnosis of hip OA. To best account for these
differences, we have adjusted for age in all the analyses.
However, if, as at the knee, cartilage volume tends to reduce
with increasing age, the power of the study to detect a dif-
ference between those with and without hip OA would
have been limited. Despite this potential limitation, we were
able to demonstrate significant reduction in cartilage vol-
ume in those with hip OA. People with no diagnosed hip
OA did not have radiographs performed in this study. Al-
though some participants may have had early radiographic
OA, they did not have sufficient symptoms to seek medical
diagnosis or intervention. Moreover, the potential for some
participants with early radiographic hip OA to have been
included in the group with no diagnosed hip OA is likely to
have underestimated any differences we observed second-
ary to non-differential misclassification. A further limitation
of this study is that we did not have information on partici-
pants’ medications. However as no pharmacological agent
has been shown to modify hip structure, failure to adjust
for medication is unlikely to have been a significant con-
founder to the results of this study. Finally, it has been no-
toriously difficult to assess structural changes at the hip
joint using MRI in epidemiological studies. Our division of
the anterior, central and posterior regions was adapted from
methods used in previously published works with smaller
sample sizes [13,14]. We extended these works, providing
the first regional prevalence data and evidence document-
ing the importance of the anatomical distribution of cartil-
age defects and BMLs at the hip. As it has been noted that
the central inferomedial region of the acetabulum is not
covered by cartilage, as in prior studies using MRI [13] and
arthroscopy [17], it is not possible to score cartilage there.Conclusion
Reduced femoral head cartilage volume and increased
prevalence of cartilage defects and BMLs are seen in
people with diagnosed hip OA compared with those
without a diagnosis of hip OA. Furthermore, for people
without diagnosed hip OA, cartilage defects and BMLs
in the anterior and central superolateral regions of the
hip are associated with reduced femoral head cartilage
volume. These data suggest that structural MRI abnor-
malities are present prior to clinical hip OA, and that
cartilage defects and BMLs in the anterior and central
superolateral regions identify early structural changes of
hip OA and may be potential therapeutic targets for the
prevention and early treatment of hip OA.
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